MEDICINOVA INC — Form 8-K
Filed November 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Form 8-K filed 2026-11-16 disclosing Item 5.02 event (departure of directors/officers or compensatory arrangements). The filing document header references the event but the full text details are not provided in this submission metadata. No specific counterparty names, dollar amounts, share counts, or dates of change are stated in the available text.
Why this rating
Officer/director governance changes are routine for public companies; without specifics on role, compensation, or departure reason, impact cannot be assessed as material relative to $62.4M market cap.
Extracted items
See more from November 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.